Uses of Levolase-IV
A fluoroquinolone with broad Gram negative and useful Gram positive and atypical cover, and high oral bioavailability that allows an early switch from infusion to tablet.
Regulatory advice on this class has tightened worldwide because of uncommon but lasting musculoskeletal and neurological effects. Current guidance reserves the class for infections where other options are unsuitable rather than treating it as a routine first choice.
- Community acquired and nosocomial pneumonia
- Complicated urinary tract infection and pyelonephritis
- Skin and soft tissue infection
- Intra abdominal infection, in combination with anaerobic cover
Indication categories, not an exhaustive list, and not a recommendation for any individual patient.
Quality-driven manufacturing behind Levolase-IV
Why Monark Criticare versus a typical supplier?
Every row is a term stated elsewhere on this site and held to in writing. Nothing here is a claim about a certificate we have not seen.
Start your critical care business with Levolase-IV — take the district before it is allocated
Send the districts you cover and the segments you already sell into. You get the rate list, the pack sizes and a straight answer on availability, usually inside one working day.
Get franchise quoteGet franchise quote for Levolase-IV
Interested in Levofloxacin 500MG Infusion IH/IP for your pharma franchise business? Fill the form and we come back with the rate list, the pack sizes and district availability.
- ✓Exclusive district rights, recorded in the agreement
- ✓Net rates, pack sizes and MRP issued before you commit
- ✓No minimum on the first two order cycles
- ✓Batch documentation and certificate of analysis with every consignment
Send enquiry
Fill in your details and we will contact you shortly.
